Second pivotal study of IDP-126 achieves all coprimary endpoints with statistical significance April 23, 2021
Baricitinib improves hair regrowth in patients with alopecia areata in second BRAVE-AA trial April 21, 2021
Phase Ib interim data on CDX-0159 for antihistamine-refractory chronic inducible urticaria March 29, 2021
Corectim Ointment 0.25% and 0.5% approved in Japan as treatment of pediatric atopic dermatitis March 25, 2021
RSS